<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The Epstein-Barr virus (EBV), a B lymphotropic virus, is involved in a growing number of immunopathological disorders benign or malignant </plain></SENT>
<SENT sid="1" pm="."><plain>The <z:hpo ids='HP_0001417'>X-linked</z:hpo> lymphoproliferative syndrome and its multifaceted clinical expression in a unique situation described in this issue by Purtilo </plain></SENT>
<SENT sid="2" pm="."><plain>Among recent findings, the association between EBV and idiopathic interstitial <z:e sem="disease" ids="C0024115" disease_type="Disease or Syndrome" abbrv="">pneumopathy</z:e> (also named cryptogenic fibrosing <z:mp ids='MP_0010922'>alveolitis</z:mp>), is to be noted (6) </plain></SENT>
<SENT sid="3" pm="."><plain>From a molecular biology view-point, in vitro immortalization of B lymphocytes by EBV is under a pluri-genic (EBNA 2, EBNA 1, LYDMA) control </plain></SENT>
<SENT sid="4" pm="."><plain>The role of EBV in <z:e sem="disease" ids="C1326912" disease_type="Neoplastic Process" abbrv="">oncogenesis</z:e> appears different in Burkitt's <z:hpo ids='HP_0002665'>Lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) and in nasopharyngeal <z:mp ids='MP_0002038'>carcinoma</z:mp> (NPC) </plain></SENT>
<SENT sid="5" pm="."><plain>In development of African <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>, EBV appears to initiate the multistage carcinogenic event, through an early and massive <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Other events include specific <z:hpo ids='HP_0000716'>depression</z:hpo> of T-cell immunity by hyperendemic <z:e sem="disease" ids="C0024530" disease_type="Disease or Syndrome" abbrv="">malaria</z:e> and c-myc onc-gene activation through chromosome translocation </plain></SENT>
<SENT sid="7" pm="."><plain>In the genesis of NPC, the role of EBV still remain to be clarified although the strong and consistent association between EBV and the undifferentiated <z:mp ids='MP_0002038'>carcinoma</z:mp> of the nasopharyngeal (NPC) around the world favours an etiological relationship </plain></SENT>
<SENT sid="8" pm="."><plain>The simple detection of IgA antibodies to VCA and EA allows early detection of the NPC, thus permitting a 95% cure rate at 5 years post-radiotherapy </plain></SENT>
<SENT sid="9" pm="."><plain>Such an early diagnostic is of paramount public health importance </plain></SENT>
<SENT sid="10" pm="."><plain>Furthermore, IgA/VCA and IgA/EA antibodies characterize <z:e sem="disease" ids="C0032927" disease_type="Neoplastic Process" abbrv="">precancerous conditions</z:e>, giving the theoretical possibility of preventive interventions </plain></SENT>
</text></document>